Mesoblast Ltd - Company Profile
Powered by 
All the data and insights you need on Mesoblast Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Mesoblast Ltd Strategy Report
- Understand Mesoblast Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Mesoblast Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Mesoblast Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Silviu Itescu
Chief Executive Officer; Director; Managing Director Executive BoardMr. Silviu Itescu has been the Chief Executive Officer since 2004. She also served as Executive Director from 2007. Prior to this, she served as Chief Executive Officer and Managing Director in 2011.
Eric Rose, MD
Chief Medical Officer; Director Executive BoardMr. Eric Rose has been the Chief Medical Officer of the company since 2022. Previously, he serves as a Director of the company since 2013. Prior to this, he served as Chairman of Columbia University’s Department of Surgery and Surgeon-in-Chief of Columbia Presbyterian Medical Center in New York. He also served as Chairman and Chief Executive Officer of SIGA Technologies.
Dagmar Rosa-Bjorkeson
Chief Operating Officer Senior ManagementMs. Dagmar Rosa-Bjorkeson has been the Chief Operating Officer of the company since 2021. Prior to this, she served as the Executive Vice President and President of Biosimilars. She also served as Executive Vice President and Chief Strategy and Development Officer of Mallinckrodt Pharmaceuticals. Ms. Bjorkeson also served as the Vice President and Head of Novartis; and Country Head and President for Novartis Sweden.
Andrew Chaponnel
Chief Financial Officer - Interim Senior ManagementMr. Andrew Chaponnel has been the Interim Chief Financial Officer of the company since 2021. Prior to this, he has held several management roles in chartered accountancy, logistics, and retail.
Jane Bell AM
Chairman Non Executive BoardMs. Jane Bell AM has been the Chairman of the company since 2024. Previously, she held Chair, director, and executive roles as a banking and finance lawyer with 30 years of corporate finance expertise focussing on international investment transactions.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer